{
    "organizations": [],
    "uuid": "f3e3e88359004707a2967adeefdc116a550131b6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shenyang-xingqi-pharmaceutical-see/brief-shenyang-xingqi-pharmaceutical-sees-fy-2017-net-profit-to-down-20-8-pct-to-28-4-pct-idUSL4N1PK2CX",
    "ord_in_thread": 0,
    "title": "BRIEF-Shenyang Xingqi Pharmaceutical sees FY 2017 net profit to down 20.8 pct to 28.4 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - Shenyang Xingqi Pharmaceutical Co Ltd :\n* Sees net profit for FY 2017 to decrease by 20.8 percent to 28.4 percent, compared to net profit of FY 2016 (54.3 million yuan)\n* Says decreased combined gross profit rate and increased R&D cost as main reasons for the forecast\nSource text in Chinese: goo.gl/sSpMd9\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-25T14:11:00.000+02:00",
    "crawled": "2018-01-26T21:30:26.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "shenyang",
        "xingqi",
        "pharmaceutical",
        "co",
        "ltd",
        "see",
        "net",
        "profit",
        "fy",
        "decrease",
        "percent",
        "percent",
        "compared",
        "net",
        "profit",
        "fy",
        "million",
        "yuan",
        "say",
        "decreased",
        "combined",
        "gross",
        "profit",
        "rate",
        "increased",
        "r",
        "cost",
        "main",
        "reason",
        "forecast",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}